Calderasib (MK-1084) is a selective KRAS G12C inhibitor with an IC50 value of 1.2 nM . Calderasib (MK-1084) exhibits significant anticancer activity, and it can be employed either as a monotherapy or in combination with the PD-1 inhibitor Pembrolizumab, providing a versatile approach for the investigation of KRAS-mutant driven cancers.
Molecular Weight:
637.08
Purity:
98.69%
CAS Number:
[2641216-67-1]
Formula:
C32H31ClF2N6O4
Target:
Ras|||Kras
T86905
* VAT and and shipping costs not included. Errors and price changes excepted